Showing results (51-60 of 89) with videos related to
Sort By:
Pageof 9
Gynecologic Oncology|January 1, 2016
Improved clinical trial enrollments for uterine leiomyosarcoma patients after gynecologic oncology partnership with a sarcoma centerS E S Lange, J Liu, D R Adkins, et al.Cancer|January 28, 1999
Differences in patterns of TP53 and KRAS2 mutations in a large series of endometrial carcinomas with or without microsatellite instabilityE M Swisher, S Peiffer-Schneider, D G Mutch, et al.Gynecologic Oncology|June 1, 1995
Potential of cervical electrosurgical excision procedure for diagnosis and treatment of cervical intraepithelial neoplasiaT J Herzog, S Williams, L M Adler, et al.Obstetrics and Gynecology|October 9, 1998
Cancer among first-degree relatives of probands with invasive and borderline ovarian cancerJ S Rader, R J Neuman, J Brady, et al.Cancer|February 1, 1990
Dexamethasone used as an antiemetic in chemotherapy protocols inhibits natural cytotoxic (NC) cell activityC B Powell, D G Mutch, M S Kao, et al.International Journal of Radiation Oncology, Biology, Physics|October 19, 1999
Lack of effect of tumor size on the prognosis of carcinoma of the uterine cervix Stage IB and IIA treated with preoperative irradiation and surgeryP W Grigsby, C A Perez, K S Chao, et al.Gynecologic Oncology|September 10, 1999
Mutational analysis of the PMS2 gene in sporadic endometrial cancers with microsatellite instabilityJ B Basil, E M Swisher, T J Herzog, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group studyG A Omura, J A Blessing, L Vaccarello, et al.Journal of the Society for Gynecologic Investigation|August 12, 1998
Analysis of MSH3 in endometrial cancers with defective DNA mismatch repairE M Swisher, D G Mutch, T J Herzog, et al.Gynecologic Oncology|June 25, 2002
Microsatellite instability, MLH1 promoter methylation, and loss of mismatch repair in endometrial cancer and concomitant atypical hyperplasiaN Horowitz, K Pinto, D G Mutch, et al.Pageof 9